<DOC>
<DOCNO>
EP-0013077
</DOCNO>
<TEXT>
<DATE>
19800709
</DATE>
<IPC-CLASSIFICATIONS>
C03C-3/17 A01N-59/16 C03C-3/12 A01N-59/26 C03C-10/00 C05B-17/00 A01N-59/20 A01N-25/08 A61K-33/34 C03C-4/00 C03C-3/16 C03C-12/00 A23K-1/175 
</IPC-CLASSIFICATIONS>
<TITLE>
glass composition and its use in a therapeutic composition, in a subcutaneous implant or in a fertilizer, algicide, fungicide, or molluscicide
</TITLE>
<APPLICANT>
int standard electric corpus<sep>international standard electric corporation<sep>international standard electric corporation320 park avenuenew york new york 10022us<sep>
</APPLICANT>
<INVENTOR>
drake cyril francisgb<sep>tripp marygb<sep>drake, cyril francis<sep>tripp, mary<sep>drake, cyril francis1 church cottages peldon roadharlow, essexgb<sep>tripp, marythe elms chickney roadhenham, bishop's stortford hertfordshiregb<sep>
</INVENTOR>
<ABSTRACT>
a copper phosphate water soluble glass composition.   the composition of the glass may be adjusted so as to release  copper at a uniform preselected rate and to produce a desired  ph in the resultant solution.  in one application of the glass  copper may be supplied to an animal from an implant formed  from a cupric oxide/phosphorus pentoxide glass which also  incorporates one or more glass modifying oxides such as  alkali metal oxides and alumina, to control the glass solubility.   suitable glasses comprise 5-55 mole % cupric oxide + alkali  metal oxides.  45-75 mole % phosphorus pentoxide, and not  more than 15 mole % alumina, where the copper oxide conÂ­ centration is not less than 5 mole %.  
</ABSTRACT>
</TEXT>
</DOC>
